Eda Adeviye Şahin, Turan Şahin, Sonat Erol, Ali Konu, Savaş Özgür Ağlamış, Arzu Bilge Tekin, Hanifi Şahin
{"title":"Diagnostic performance of ChatGPT in adnexal mass classification: A comparative study with frozen section and final histopathology.","authors":"Eda Adeviye Şahin, Turan Şahin, Sonat Erol, Ali Konu, Savaş Özgür Ağlamış, Arzu Bilge Tekin, Hanifi Şahin","doi":"10.4274/tjod.galenos.2026.99602","DOIUrl":"https://doi.org/10.4274/tjod.galenos.2026.99602","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the diagnostic performance of ChatGPT in classifying adnexal masses as benign, borderline, or malignant, and to compare its performance with intraoperative frozen-section analysis, using final histopathology as the reference standard.</p><p><strong>Materials and methods: </strong>This retrospective, observational, comparative study included 259 patients who underwent surgery for ovarian masses between January 2021 and July 2025. Preoperative clinical data, laboratory parameters, and ultrasonographic findings were recorded. ChatGPT assessments were performed using structured clinical inputs without prompt optimization. Frozen section diagnoses and ChatGPT classifications were compared with final histopathological results. Diagnostic performance metrics, including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), Cohen's kappa coefficient, and area under the curve (AUC), were calculated.</p><p><strong>Results: </strong>According to final histopathology, 83.4% of cases were benign, 7.7% were borderline, and 8.9% were malignant. Frozen section analysis demonstrated high diagnostic accuracy, with sensitivity and specificity of 94.4% and 100%, respectively, when borderline cases were excluded. In comparison, ChatGPT showed a sensitivity of 90.0% and a specificity of 92.5%. The PPV for ChatGPT (56.3%) was markedly lower than that for frozen section (100%), whereas NPV values were comparable (98.9% vs. 99.5%). When borderline tumors were classified as malignant, ChatGPT's performance declined further, with a sensitivity of 74.4%, a specificity of 79.6%, and a PPV of 42.1%. Receiver operating characteristic analysis showed AUCs of 0.967 for the frozen section and 0.893 for ChatGPT. ChatGPT demonstrated a higher rate of false-positive classifications, particularly in the borderline and malignant categories.</p><p><strong>Conclusion: </strong>Frozen section analysis remains a highly reliable method for intraoperative evaluation of ovarian tumors. Although ChatGPT demonstrates good discriminative ability and high NPV, its lower specificity and PPV limit its role as a standalone diagnostic tool. ChatGPT may serve as a complementary decision-support tool, particularly in ruling out malignancy, but cannot replace histopathological evaluation.</p>","PeriodicalId":45340,"journal":{"name":"Turkish Journal of Obstetrics and Gynecology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149411688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frengki Prabowo Saputro Wijayanto, Artha Maressa Theodora Simanjuntak, Priscilla Clarita Neda Br Sirait, Alifian Arkan Zaky Kusnadi, I Putu Krisna Agastya Artawan, Roy Novri Ramadhan, Wendy Wirya, I Gede Wikania Wira Wiguna, Ni Wayan Armerinayanti
{"title":"PD-1/PD-L1 inhibitors plus chemotherapy in cervical cancer: A systematic review and meta-analysis.","authors":"Frengki Prabowo Saputro Wijayanto, Artha Maressa Theodora Simanjuntak, Priscilla Clarita Neda Br Sirait, Alifian Arkan Zaky Kusnadi, I Putu Krisna Agastya Artawan, Roy Novri Ramadhan, Wendy Wirya, I Gede Wikania Wira Wiguna, Ni Wayan Armerinayanti","doi":"10.4274/tjod.galenos.2026.70923","DOIUrl":"https://doi.org/10.4274/tjod.galenos.2026.70923","url":null,"abstract":"<p><strong>Objective: </strong>This systematic review and meta-analysis aimed to appraise the comparative efficacy and safety of appending programmed death-1 (PD-1) or PD-ligand 1 (PD-L1) checkpoint blockade to standard chemotherapy in cervical cancer, with prespecified analyses across both the full randomized cohort and the PD-L1-enriched subset.</p><p><strong>Materials and methods: </strong>In accordance with PRISMA 2020 guidelines, a comprehensive electronic search was conducted across PubMed, Scopus, the Cochrane Central Register of Controlled Trials, and ProQuest up to September 2025, targeting phase III randomized trials that incorporated PD-1 or PD-L1 blockade into a chemotherapy backbone. Pooled effect estimates were derived using random-effects modeling, generating hazard ratios (HR) for survival endpoints and risk ratios (RR) for tumor response. Methodological rigor was gauged with the Cochrane Risk of Bias 2 tool, while small-study effects were explored through DOI plots supplemented by the LFK index.</p><p><strong>Results: </strong>Five phase III randomized controlled trials comprising 3,302 patients were included. The addition of PD-1/PD-L1 inhibitors to chemotherapy significantly improved overall survival [HR: 0.66, 95% confidence interval (CI): 0.60-0.73] and progression-free survival (HR: 0.68, 95% CI: 0.60-0.78), with low heterogeneity I2=0%. Objective response rates was modestly increased (RR: 1.14, 95% CI: 1.02-1.26). Survival benefits were mainly driven by PD-1 inhibitors (pembrolizumab and cadonilimab), whereas PD-L1 inhibitors showed less consistent effects. Absolute survival gains within 24 months were modest. Immune-related endocrine events, particularly hyperthyroidism and hypothyroidism, were more frequent, but severe toxicities (grade ≥3) were not significantly increased.</p><p><strong>Conclusion: </strong>PD-1-targeting immunochemotherapy prolongs survival in cervical cancer while maintaining acceptable tolerability, positioning it as a leading treatment option for eligible patients. Further biomarker-driven and head-to-head trials are needed to optimize treatment selection.</p>","PeriodicalId":45340,"journal":{"name":"Turkish Journal of Obstetrics and Gynecology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149335530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Machine learning prediction of IVF outcomes in unexplained infertility.","authors":"Yeliz Kaya, Yunus Aydın, Coşkun Kaya, Tuğba Tahta, Özer Çelik, Şermin Özkaya Karabıçak","doi":"10.4274/tjod.galenos.2026.10663","DOIUrl":"https://doi.org/10.4274/tjod.galenos.2026.10663","url":null,"abstract":"<p><strong>Objective: </strong>To develop and evaluate machine learning (ML) models to predict clinical pregnancy (CP) outcomes in couples with unexplained infertility (UI) undergoing in vitro fertilization (IVF), thereby enhancing early treatment decision-making and patient counseling.</p><p><strong>Materials and methods: </strong>A retrospective analysis was conducted on 145 couples diagnosed with UI and treated at a single-center IVF clinic. Live birth data were not available; therefore, CP was used as the primary outcome. Demographic, clinical, and laboratory parameters were collected, and five ML algorithms-light gradient boosting machine (LGBM), random forest, logistic regression, extra trees classifier, and eXtreme gradient boosting-were applied to predict CP outcomes. Model performance was assessed using the area under the receiver operating characteristic curve (ROC-AUC), accuracy, sensitivity, and specificity. Permutation-based feature importance analysis was performed to identify key predictive variables.</p><p><strong>Results: </strong>Among the evaluated models, the LGBM model achieved the highest test-set ROC-AUC (0.712) and an accuracy of 65.2%. Given the small test sample and the lack of external validation, these findings should be interpreted as exploratory. Variables receiving the highest permutation feature-importance scores included total gonadotropin dose, initial gonadotropin dose, total sperm count, progressive motile sperm count, and infertility duration. These findings should be interpreted as exploratory and do not establish that these variables are independent predictors of CP.</p><p><strong>Conclusion: </strong>This study presents the first ML-based approach tailored to predicting CP outcomes in couples with UI undergoing IVF. The results highlight the potential of artificial intelligence to inform personalized reproductive care. These exploratory findings demonstrate the feasibility of applying ML methods in UI. Larger prospective multicenter studies are required to determine whether clinically useful prediction models can be developed.</p>","PeriodicalId":45340,"journal":{"name":"Turkish Journal of Obstetrics and Gynecology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Relationship between pre-micro-TESE serum anti-Müllerian hormone (AMH) levels and sperm retrieval success in patients diagnosed with non-obstructive azoospermia: A retrospective study.","authors":"Ayşen Yücetürk, Nuri Peker, Özge Karaosmanoğlu, Tansu Güdelci, Burak Elmas, İlke Özer Aslan, Bülent Tıraş","doi":"10.4274/tjod.galenos.2026.47041","DOIUrl":"https://doi.org/10.4274/tjod.galenos.2026.47041","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to evaluate the relationship between serum anti-Müllerian hormone (AMH) levels measured before microdissection testicular sperm extraction (mTESE) and sperm retrieval (SR) success in men diagnosed with non-obstructive azoospermia (NOA).</p><p><strong>Materials and methods: </strong>The present study was based on retrospective evaluation of 58 patients who presented to our clinic between January 2025 and April 2026, were diagnosed with NOA, and underwent mTESE. Patient age, duration of infertility, serum AMH, follicle-stimulating hormone (FSH), luteinizing hormone (LH) testosterone levels, and the AMH/testosterone ratio were recorded. Demographic and hormonal parameters were compared between the successful SR (+SR) and unsuccessful SR (-SR) groups after mTESE.</p><p><strong>Results: </strong>The mean age of the study population (n=58) was 35.53±6.10 years, and the mean infertility duration was 8.25±4.53 years. The mean serum AMH level was 2.42±2.35 ng/mL (median: 2.14 ng/mL; range: 0.01-9.87 ng/mL). +SR was achieved in 29 patients (50%), whereas no sperm could be retrieved in the remaining 29 patients (50%). Comparison of two groups revealed no statistically significant difference between the sperm-positive and sperm-negative groups with respect to age, duration of infertility, AMH, FSH, LH, testosterone, or the AMH/testosterone ratio. Receiver operating characteristic analysis revealed an area under the curve value of 0.531 for AMH (95% confidence interval: 0.379-0.683, p=0.690), indicating no significant predictive value. Binomial logistic regression analysis also found no variable to be a significant predictor of +SR.</p><p><strong>Conclusion: </strong>Serum AMH level, either alone or in combination with other hormonal parameters, was not found to be a reliable clinical biomarker for predicting SR outcomes in men with NOA undergoing mTESE. Larger, prospective, etiologically stratified studies are required to determine the definitive role of AMH in preoperative evaluation.</p>","PeriodicalId":45340,"journal":{"name":"Turkish Journal of Obstetrics and Gynecology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149301036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparison of embryological and clinical outcomes of ICSI cycles using ejaculated versus testicular sperm (TESA/mTESE) in men with cryptozoospermia: A retrospective cohort study.","authors":"Ayşen Yücetürk, Nuri Peker, Özge Karaosmanoğlu, Burak Elmas, İlke Özer Aslan, Tansu Güdelci, Bülent Tıraş","doi":"10.4274/tjod.galenos.2026.44592","DOIUrl":"https://doi.org/10.4274/tjod.galenos.2026.44592","url":null,"abstract":"<p><strong>Objective: </strong>To compare the embryological and clinical outcomes of intracytoplasmic sperm injection (ICSI) cycles using ejaculated versus testicular sperm (TESA/mTESE) in men with cryptozoospermia.</p><p><strong>Materials and methods: </strong>This retrospective cohort study included 127 ICSI cycles performed in couples with male cryptozoospermia at the Acıbadem Maslak Hospital Assisted Reproductive Technology Center between 2017 and 2026. Cycles were grouped according to sperm source as ejaculated (n=58) or testicular (n=69; mTESE, n=51; TESA, n=18). The primary outcome was the pregnancy rate per embryo transfer. Multivariable logistic regression was used to adjust for confounders.</p><p><strong>Results: </strong>Baseline characteristics were similar, except for a higher number of previous IVF attempts in the testicular sperm group (p=0.032) and a more frequent history of miscarriage in the ejaculated sperm group (15.5% vs. 4.5%, p=0.037). The testicular sperm group had more day 5 blastocysts (median 5 vs. 3, p=0.004) and a higher blastocyst formation rate (57.2% vs. 34.3%, p<0.001), but also more grade 3 blastocysts (p<0.001). Per embryo transfer, pregnancy (80.0% vs. 54.5%, p=0.006) and clinical pregnancy rates (78.0% vs. 47.3%, p=0.001) were higher in the ejaculated sperm group, whereas live birth rates were similar (48.0% vs. 45.5%, p=0.794). After adjustment for female age, previous IVF attempts, embryo stage at transfer and embryo quality, sperm source was not independently associated with pregnancy (adjusted odds ratio: 1.94, 95% confidence interval: 0.71-5.26, p=0.195); blastocyst-stage transfer and grade 1 embryo quality were the independent predictors.</p><p><strong>Conclusion: </strong>In men with cryptozoospermia, testicular sperm increased blastocyst yield but did not improve pregnancy or live birth rates compared with ejaculated sperm. When ejaculated spermatozoa are available, routine surgical sperm retrieval does not appear to provide a clinical advantage.</p>","PeriodicalId":45340,"journal":{"name":"Turkish Journal of Obstetrics and Gynecology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149301039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prenatal diagnosis of severe glutaric acidemia type II due to a novel homozygous ETFDH frameshift variant: Case report and literature review.","authors":"Seda Kaplan, Büşra Berfin Polat, Rauf Melekoğlu","doi":"10.4274/tjod.galenos.2026.09552","DOIUrl":"https://doi.org/10.4274/tjod.galenos.2026.09552","url":null,"abstract":"<p><p>Glutaric acidemia type II (GA2) is a rare autosomal recessive fatty acid oxidation disorder that can present prenatally with bilateral hyperechoic cystic kidneys. We report a 23-year-old gravida 2 woman who was referred at 18+2 weeks for suspected fetal renal anomalies, with a history of consanguinity and a prior unexplained neonatal death. Quantitative fluorescent polymerase chain reaction and microarray were normal; whole-exome sequencing identified a novel homozygous <i>ETFDH</i> frameshift variant (c.1200_1203del; <i>p.His401GlnfsTer3</i>). The parents were heterozygous, and the variant was classified as likely pathogenic. The family terminated the pregnancy after counseling. This case highlights both GA2 in the differential diagnosis of fetal renal anomalies and the value of prenatal exome sequencing for diagnosis and counseling.</p>","PeriodicalId":45340,"journal":{"name":"Turkish Journal of Obstetrics and Gynecology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149231288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Sexual function and surgical outcomes after vaginal natural orifice transluminal endoscopic surgery versus total laparoscopic hysterectomy.","authors":"Hanne Bulat Çim, Melis Altuğ İnan, Şeyma Taştekin, Neslişah Ar, Bilge Kapudere, Meryem Hocaoğlu, Abdulkadir Turgut","doi":"10.4274/tjod.galenos.2026.57431","DOIUrl":"https://doi.org/10.4274/tjod.galenos.2026.57431","url":null,"abstract":"<p><strong>Objective: </strong>To examine whether vaginal natural orifice transluminal endoscopic surgery (vNOTES) and total laparoscopic hysterectomy (TLH) differ in postoperative sexual health, patient-reported recovery measures, and perioperative outcomes.</p><p><strong>Materials and methods: </strong>Sexually active women treated with vNOTES or TLH for benign gynaecological indications between January 2023 and January 2026 were included in this ambispective cohort. Clinical and operative information was retrieved retrospectively, while patient-reported postoperative data were obtained prospectively a minimum of six months after surgery. Sexual function was measured with the Female Sexual Function Index (FSFI). Additional outcomes included dyspareunia, time to resumption of sexual intercourse, return to work, postoperative satisfaction, and willingness to undergo the same procedure again. Selected outcomes were further examined using multivariable regression models incorporating clinically relevant confounding variables.</p><p><strong>Results: </strong>The analysis comprised 159 women, of whom 105 underwent TLH and 54 underwent vNOTES. Compared with TLH, vNOTES was associated with a shorter operative duration [160 (60) vs. 198 (90) minutes, p<0.01], earlier return to sexual intercourse [8 (3) vs. 9 (4) weeks, p<0.01], and higher postoperative satisfaction [10 (9-10) vs. 9 (8-10), p<0.01]. In adjusted analyses, the associations with shorter operative time [β=-27.24, 95% confidence interval (CI): -50.62 to -3.86; p=0.02] and earlier resumption of intercourse (β=-1.60 weeks, 95% CI: -2.93 to -0.27; p=0.01) persisted. No significant differences were identified in FSFI-based sexual function, dyspareunia, time to return to work, or composite adverse events.</p><p><strong>Conclusion: </strong>vNOTES and TLH showed comparable postoperative sexual function and dyspareunia outcomes. vNOTES was associated with an earlier return to sexual intercourse, greater postoperative satisfaction, and shorter operative duration. Further prospective multicentre research is required to clarify longer-term sexual outcomes after these procedures.</p>","PeriodicalId":45340,"journal":{"name":"Turkish Journal of Obstetrics and Gynecology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149231313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Chromosomal abnormalities in isolated persistent left superior vena cava: A systematic review and meta-analysis","authors":"Süreyya Sarıdaş Demir, Bülent Demir","doi":"10.4274/tjod.galenos.2026.01678","DOIUrl":"10.4274/tjod.galenos.2026.01678","url":null,"abstract":"<p><p>Persistent left superior vena cava (PLSVC) is the most common systemic venous anomaly detected prenatally, yet the risk of chromosomal abnormalities in truly isolated cases remains uncertain. This systematic review and meta-analysis aimed to determine the rate of chromosomal anomalies in fetuses with isolated PLSVC by including only fetuses who underwent chromosomal analysis. A systematic search of PubMed/MEDLINE, EMBASE, and the Cochrane Library was performed from January 2000 through March 2026. Studies reporting chromosomal data for fetuses with sonographically confirmed isolated PLSVC were eligible. Isolated PLSVC was defined as PLSVC in the absence of intracardiac or extracardiac structural anomalies, irrespective of the presence of the right superior vena cava. Only isolated fetuses with prenatal or postnatal chromosomal analysis were included; untested fetuses were not assumed to be chromosomally normal. The pooled proportion was calculated as the total number of events divided by the total number of genetically assessed isolated fetuses, with 95% confidence intervals (CIs) calculated using the Wilson score method. Twelve studies were included, comprising 892 isolated PLSVC fetuses, of whom 302 underwent genetic testing. Eight chromosomal anomalies were identified, yielding a pooled chromosomal anomaly rate of 2.6% (95% CI: 1.3-5.1%). In the leave-one-out sensitivity analysis, the pooled rate ranged from 1.3% to 4.8%. The risk of chromosomal abnormalities in isolated PLSVC is low but not negligible. Because genetic testing was performed more often in higher-risk pregnancies, this estimate probably overestimates the background risk. The available evidence does not support a universal recommendation for invasive prenatal diagnosis based solely on an isolated PLSVC; decision-making should be individualized based on maternal age, serum screening or cell-free DNA results, nuchal translucency, detailed fetal anatomical assessment, and patient preference.</p>","PeriodicalId":45340,"journal":{"name":"Turkish Journal of Obstetrics and Gynecology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149018168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Giant clitoral inclusion cyst without prior genital mutilation: A case report.","authors":"Burak Tatar, Gülbin Yıldıran","doi":"10.4274/tjod.galenos.2026.58458","DOIUrl":"https://doi.org/10.4274/tjod.galenos.2026.58458","url":null,"abstract":"<p><p>Clitoral epidermoid inclusion cysts are rare benign lesions that may cause physical discomfort, genital disfigurement, and psychosocial distress when they become large. A 47-year-old woman presented with a rapidly enlarging clitoral mass measuring approximately 11 cm. She had no history of female genital mutilation, vulvar trauma, or vulvar surgery. Clinical, hormonal, and imaging findings did not suggest hyperandrogenism, virilization, or malignancy. Complete cyst excision, accompanied by clitoral hood plasty and labioplasty, was performed with careful preservation of the dorsal clitoral neurovascular structures. Histopathology confirmed an epidermoid inclusion cyst. The postoperative course was uneventful.</p>","PeriodicalId":45340,"journal":{"name":"Turkish Journal of Obstetrics and Gynecology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149196929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparison of maternal serum calcidiol and microRNA-1323 expression in term and early preterm births.","authors":"Danil Armand, Yusrawati Yusrawati, Jamsari Jamsari, Masrul Masrul","doi":"10.4274/tjod.galenos.2026.79054","DOIUrl":"https://doi.org/10.4274/tjod.galenos.2026.79054","url":null,"abstract":"<p><strong>Objective: </strong>Preterm birth remains a leading cause of neonatal morbidity and mortality. Maternal vitamin D status and epigenetic regulation may contribute to its pathogenesis. This study aimed to analyze differences in subject characteristics, calcidiol [25(OH)D] levels, and maternal blood microRNA-1323 (miRNA-1323) expression between term and early preterm (28-34 weeks) deliveries.</p><p><strong>Materials and methods: </strong>An analytical observational study with a comparative cross-sectional design was conducted among 80 parturient women, including 40 term (37-42 weeks) and 40 early preterm deliveries. Calcidiol levels were measured using enzyme-linked immunosorbent assay, and miRNA-1323 expression was analyzed by quantitative reverse transcription polymerase chain reaction with the ΔCq method. Statistical analyses included normality, non-parametric, and correlation tests (p<0.05).</p><p><strong>Results: </strong>Mean maternal calcidiol levels were significantly higher in the early preterm group than in the term group (27.49±9.18 vs. 23.34±9.64 ng/mL; p=0.022), although both remained below the normal range. Median miRNA-1323 expression was also higher in the early preterm group, but not statistically significant (p=0.709). No significant correlation was observed between maternal calcidiol levels and miRNA-1323 expression in either group, indicating that these biomarkers were not directly associated in the present study and supporting further investigation into their individual contributions to early preterm birth.</p><p><strong>Conclusion: </strong>Maternal calcidiol levels differed significantly between term and early preterm deliveries, whereas miRNA-1323 showed a non-significant increasing trend. Both biomarkers may reflect biological changes associated with preterm birth.</p>","PeriodicalId":45340,"journal":{"name":"Turkish Journal of Obstetrics and Gynecology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149082323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}